Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -373,306 | -310,811 | -111,973 | N/A | N/A |
| Depreciation Amortization | 15,100 | 9,929 | 5,181 | N/A | N/A |
| Accounts receivable | 70 | -14,974 | 34 | N/A | N/A |
| Accounts payable and accrued liabilities | -15,720 | -11,349 | -3,082 | N/A | N/A |
| Other Working Capital | -61,094 | -57,956 | -31,838 | N/A | N/A |
| Other Operating Activity | 137,319 | 148,378 | 2,463 | 0 | -151,539 |
| Operating Cash Flow | $-297,631 | $-236,783 | $-139,215 | $N/A | $-151,539 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 922 | 385,753 | N/A | N/A | N/A |
| PPE Investments | -15,739 | -10,362 | -4,221 | N/A | N/A |
| Purchase Sale Intangibles | -134 | -38 | 310 | N/A | N/A |
| Other Investing Activity | -299,906 | -481,042 | 20,253 | 0 | -102,024 |
| Investing Cash Flow | $-314,723 | $-105,651 | $16,032 | $N/A | $-102,024 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 794,624 | 791,942 | 370 | N/A | N/A |
| Other Financing Activity | -4,059 | -2,338 | -814 | 0 | 378,759 |
| Financing Cash Flow | $790,565 | $789,604 | $-444 | $N/A | $378,759 |
| Exchange Rate Effect | -772 | 12 | -2,354 | N/A | -1,401 |
| Beginning Cash Position | 786,031 | 786,031 | 786,031 | N/A | 688,938 |
| End Cash Position | 963,470 | 1,233,213 | 660,050 | N/A | 812,733 |
| Net Cash Flow | $177,439 | $447,182 | $-125,981 | $N/A | $123,795 |
| Free Cash Flow | |||||
| Operating Cash Flow | -297,631 | -236,783 | -139,215 | N/A | -151,539 |
| Capital Expenditure | -15,739 | -10,362 | -4,274 | N/A | N/A |
| Free Cash Flow | -313,370 | -247,145 | -143,489 | 0 | -151,539 |